Comparing the current results to its competitors, Ekso Bionics Holdings Inc reported Revenue decrease in the 1 quarter 2026 year on year by -26.09 %, faster than the overall decrease of Ekso Bionics Holdings Inc 's competitors by -4.16 %, recorded in the same quarter.
Ekso Bionics Holdings Inc 's Comment on Competition and Industry Peers
The company operates in the highly competitive and rapidly evolving AI cloud market. Its primary competitors include CoreWeave, Crusoe Energy, Lambda Labs, and Nebius Group. Additional competitors identified in company filings are AlterG, Aretech, Bionik Laboratories, Cyberdyne, Hocoma, Levitate, Ottobock, Parker Hannafin, Reha Technology, ReWalk, ReWalk Robotics, Skel-ex, and SuitX. Competitors often possess advantages such as greater name recognition, longer operating histories, higher operating margins, established customer relationships, broader geographic presence, larger marketing budgets, stronger financial and operational resources, more robust internal controls and systems, and better-established supplier relationships. The company focuses on innovation and service differentiation to attract and retain customers within this competitive environment.
January 8, 2024
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an established leader in the application and development of exoskeleton technology for healthcare and industrial sectors, has announced an innovative leap in gait therapy with the debut of its revolutionary GaitCoach software. The software is set to significantly enhance EksoNR capabilities, marking an exciting advancement in robotics-assisted rehabilitation. Situated in San Rafael, California, Ekso Bionics is a pioneering figure in the robotics world. The company s cutting-edge advancements in exoskeleton technology have generated transformative solutions, changing the landscape of physical rehabilitation and industrial workforces. The latest addition to their por...
Publicly Traded Peers of Ekso Bionics Holdings Inc
Ss Innovations International Inc Share Performance
0.00%
This Quarter
Ss Innovations International Inc
Profile
Avra Medical Robotics Inc's business model revolves around developing and commercializing medical robotics and digital technologies for use in surgical procedures. They aim to enhance surgical precision, efficiency, and patient outcomes by providing advanced robotic systems to healthcare facilities.
Sources:
Ekso Bionics Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Ekso Bionics Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
